| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2024 | SYK Stryker Corp | Stryker Ronda E57 | Director, 10% Owner | Sell | 293,442 | $341.97 | $100,349,380.90 | -0.6% | -4.2% | +17.5% | |
| Feb 6, 2024 | STIM Neuronetics, Inc. | Furlong Stephen74 | EVP, CFO And Treasurer | Sell | 5,813 | $3.39 | $19,706.07 | -1.1% | +6.5% | -7.1% | |
| Feb 6, 2024 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 10,000 | $0.29 | $2,900.00 | +13.2% | -16.8% | -94.4% | |
| Feb 5, 2024 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Director | Sell | 29,350 | $87.49 | $2,567,753.55 | -26.7% | -1.1% | -17.1% | |
| Feb 5, 2024 | SONX Sonendo, Inc. | Chen Roy T | Chief Talent Officer | Sell | 740 | $0.15 | $111.74 | -0.3% | - | - | |
| Feb 5, 2024 | SONX Sonendo, Inc. | Watts Michael Patrick | Chief Financial Officer | Sell | 1,614 | $0.15 | $243.71 | -0.3% | - | - | |
| Feb 5, 2024 | SONX Sonendo, Inc. | Bergheim Bjarne | President And CEO | Sell | 2,685 | $0.15 | $405.44 | -0.1% | - | - | |
| Feb 5, 2024 | NPCE Neuropace Inc | Morrell Martha59 | Chief Medical Officer | Sell | 17,589 | $15.09 | $265,400.51 | -10.0% | -12.6% | -9.9% | |
| Feb 5, 2024 | ATEC Alphatec Holdings, Inc. | Hunsaker Craig E61 | EVP, People &Culture | Sell | 39,056 | $16.51 | $644,764.56 | -1.5% | -18.8% | -25.7% | |
| Feb 2, 2024 | SYK Stryker Corp | Golston Allan C. | Director | Sell | 3,273 | $341.00 | $1,116,093.00 | -18.7% | -4.5% | +14.4% | |
| Feb 2, 2024 | SIBN Si-Bone, Inc. | Dunn Jeffrey W70 | Director | Sell | 335 | $20.30 | $6,799.43 | -0.7% | -28.8% | -18.3% | |
| Feb 2, 2024 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 36,620 | $16.47 | $603,131.40 | -5.4% | -20.5% | -29.1% | |
| Feb 2, 2024 | MASS 908 Devices Inc. | Griffith Joseph H. IV81 | Chief Financial Officer | Sell | 15,409 | $7.06 | $108,765.48 | -5.5% | -20.8% | -65.1% | |
| Feb 2, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 6,418 | $1.17 | $7,533.57 | - | -9.5% | -31.9% | |
| Feb 2, 2024 | ATEC Alphatec Holdings, Inc. | Lish Scott61 | Chief Operating Officer | Sell | 25,210 | $16.47 | $415,208.70 | -4.6% | -20.5% | -29.1% | |
| Feb 2, 2024 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 10,200 | $0.36 | $3,646.00 | +5.1% | -30.4% | -94.7% | |
| Feb 1, 2024 | RXST Rxsight, Inc. | Link William J Phd | Director | Sell | 28,250 | $49.67 | $1,403,120.09 | -33.5% | +13.9% | -32.0% | |
| Feb 1, 2024 | EW Edwards Lifesciences Corp | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 7,255 | $78.29 | $567,993.95 | -27.4% | +7.1% | -8.0% | |
| Feb 1, 2024 | MASS 908 Devices Inc. | Brown Christopher D.85 | Chief Product Officer | Sell | 3,957 | $7.01 | $27,730.32 | -0.2% | -21.2% | -65.3% | |
| Feb 1, 2024 | RXST Rxsight, Inc. | Weinberg Eric57 | Chief Commercial Officer | Sell | 10,000 | $50.00 | $500,004.00 | -3.2% | +13.9% | -32.0% | |
| Feb 1, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | Chief Operating Officer | Sell | 7,129 | $49.29 | $351,411.00 | -7.9% | +13.9% | -32.0% | |
| Feb 1, 2024 | MASS 908 Devices Inc. | Knopp Kevin J.79 | President And CEO | Sell | 9,071 | $7.00 | $63,460.64 | -1.1% | -21.2% | -65.3% | |
| Feb 1, 2024 | MASS 908 Devices Inc. | Turner Michael S.77 | Chief Legal &Admin Officer | Sell | 5,232 | $6.99 | $36,558.71 | -19.3% | -21.2% | -65.3% | |
| Feb 1, 2024 | ISRG Intuitive Surgical Inc | Brosius Mark56 | SVP &Chief Mfg And Supply Cha | Sell | 39 | $378.41 | $14,757.99 | -8.0% | -3.2% | +49.0% | |
| Feb 1, 2024 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 15,000 | $85.45 | $1,281,750.00 | -53.4% | +32.8% | -23.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.